ML Gomez, C Gomez‐Raposo, F Lobo Samper - Cancer, 2008 - Wiley Online Library
In a recent issue of Cancer, Khorana et al. 1 concluded that venous thromboembolic events (VTEs) are an increasingly frequent complication of hospitalization in cancer patients. We …
CW Francis - Journal of clinical oncology, 2009 - ascopubs.org
This is a literature review of the frequency of venous thromboembolism in hospitalized patients with cancer and of the available evidence supporting the use of …
N Kucher, D Spirk, I Baumgartner, L Mazzolai, W Korte… - Annals of oncology, 2010 - Elsevier
Background: Venous thromboembolism (VTE) prophylaxis remains underutilized, particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized …
M Di Nisio, M Candeloro, AWS Rutjes, V Galli… - Thrombosis research, 2018 - Elsevier
Background Cancer patients hospitalized for an acute medical illness are considered to be at high risk of venous thromboembolism (VTE). Information on bleeding and symptomatic …
AA Khorana, CW Francis, E Culakova… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. Venous thromboembolism (VTE) contributes to morbidity and mortality in cancer patients and is a frequent complication of anticancer therapy. In the current study, the …
H Abdel-Razeq, F Albadainah, S Hijjawi… - Journal of thrombosis …, 2011 - Springer
Cancer patients are at higher risk for venous thromboembolism (VTE). Anticoagulants, when used for prophylaxis, had successfully reduced the incidence of VTE in high risk patients …
Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk …
Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized …
AA Khorana, M Dalal, J Lin, GC Connolly - Cancer, 2013 - Wiley Online Library
BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …